UniProt ID | AUTS2_HUMAN | |
---|---|---|
UniProt AC | Q8WXX7 | |
Protein Name | Autism susceptibility gene 2 protein | |
Gene Name | AUTS2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1259 | |
Subcellular Localization | Nucleus . Cytoplasm, cytoskeleton . Cell projection, growth cone . Detected both in cytoplasm and nucleus. Colocalizes with RAC1 at actin-rich growth cones. Detected on the promoter region of actively transcribed genes. | |
Protein Description | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. [PubMed: 25519132 The PRC1-like complex that contains PCGF5, RNF2, CSNK2B, RYBP and AUTS2 has decreased histone H2A ubiquitination activity, due to the phosphorylation of RNF2 by CSNK2B] | |
Protein Sequence | MDGPTRGHGLRKKRRSRSQRDRERRSRGGLGAGAAGGGGAGRTRALSLASSSGSDKEDNGKPPSSAPSRPRPPRRKRRESTSAEEDIIDGFAMTSFVTFEALEKDVALKPQERVEKRQTPLTKKKREALTNGLSFHSKKSRLSHPHHYSSDRENDRNLCQHLGKRKKMPKALRQLKPGQNSCRDSDSESASGESKGFHRSSSRERLSDSSAPSSLGTGYFCDSDSDQEEKASDASSEKLFNTVIVNKDPELGVGTLPEHDSQDAGPIVPKISGLERSQEKSQDCCKEPIFEPVVLKDPCPQVAQPIPQPQTEPQLRAPSPDPDLVQRTEAPPQPPPLSTQPPQGPPEAQLQPAPQPQVQRPPRPQSPTQLLHQNLPPVQAHPSAQSLSQPLSAYNSSSLSLNSLSSSRSSTPAKTQPAPPHISHHPSASPFPLSLPNHSPLHSFTPTLQPPAHSHHPNMFAPPTALPPPPPLTSGSLQVAGHPAGSTYSEQDILRQELNTRFLASQSADRGASLGPPPYLRTEFHQHQHQHQHTHQHTHQHTFTPFPHAIPPTAIMPTPAPPMFDKYPTKVDPFYRHSLFHSYPPAVSGIPPMIPPTGPFGSLQGAFQPKTSNPIDVAARPGTVPHTLLQKDPRLTDPFRPMLRKPGKWCAMHVHIAWQIYHHQQKVKKQMQSDPHKLDFGLKPEFLSRPPGPSLFGAIHHPHDLARPSTLFSAAGAAHPTGTPFGPPPHHSNFLNPAAHLEPFNRPSTFTGLAAVGGNAFGGLGNPSVTPNSMFGHKDGPSVQNFSNPHEPWNRLHRTPPSFPTPPPWLKPGELERSASAAAHDRDRDVDKRDSSVSKDDKERESVEKRHSSHPSPAPVLPVNALGHTRSSTEQIRAHLNTEAREKDKPKERERDHSESRKDLAADEHKAKEGHLPEKDGHGHEGRAAGEEAKQLARVPSPYVRTPVVESARPNSTSSREAEPRKGEPAYENPKKSSEVKVKEERKEDHDLPPEAPQTHRASEPPPPNSSSSVHPGPLASMPMTVGVTGIHPMNSISSLDRTRMMTPFMGISPLPGGERFPYPSFHWDPIRDPLRDPYRELDIHRRDPLGRDFLLRNDPLHRLSTPRLYEADRSFRDREPHDYSHHHHHHHHPLSVDPRREHERGGHLDERERLHMLREDYEHTRLHSVHPASLDGHLPHPSLITPGLPSMHYPRISPTAGNQNGLLNKTPPTAALSAPPPLISTLGGRPVSPRRTTPLSAEIRERPPSHTLKDIEAR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Methylation | --MDGPTRGHGLRKK --CCCCCCCCHHHHH | 37.94 | - | |
26 | Phosphorylation | QRDRERRSRGGLGAG HHHHHHHHHCCCCCC | 41.31 | 28555341 | |
27 | Methylation | RDRERRSRGGLGAGA HHHHHHHHCCCCCCC | 41.19 | - | |
47 | Phosphorylation | AGRTRALSLASSSGS CHHHHHHHHHHCCCC | 22.39 | 28111955 | |
50 | Phosphorylation | TRALSLASSSGSDKE HHHHHHHHCCCCCCC | 30.26 | 28111955 | |
51 | Phosphorylation | RALSLASSSGSDKED HHHHHHHCCCCCCCC | 32.86 | 28111955 | |
52 | Phosphorylation | ALSLASSSGSDKEDN HHHHHHCCCCCCCCC | 39.56 | 28111955 | |
54 | Phosphorylation | SLASSSGSDKEDNGK HHHHCCCCCCCCCCC | 47.67 | 28111955 | |
64 | Phosphorylation | EDNGKPPSSAPSRPR CCCCCCCCCCCCCCC | 47.89 | 28111955 | |
65 | Phosphorylation | DNGKPPSSAPSRPRP CCCCCCCCCCCCCCC | 50.39 | 28111955 | |
68 | Phosphorylation | KPPSSAPSRPRPPRR CCCCCCCCCCCCCCC | 55.42 | 28111955 | |
80 | Phosphorylation | PRRKRRESTSAEEDI CCCCCCCCCCCCHHH | 26.33 | 27732954 | |
81 | Phosphorylation | RRKRRESTSAEEDII CCCCCCCCCCCHHHH | 27.48 | 27732954 | |
82 | Phosphorylation | RKRRESTSAEEDIID CCCCCCCCCCHHHHH | 42.85 | 27732954 | |
94 | Phosphorylation | IIDGFAMTSFVTFEA HHHHCHHHCEEHHHH | 18.64 | 27732954 | |
95 | Phosphorylation | IDGFAMTSFVTFEAL HHHCHHHCEEHHHHH | 12.48 | 27732954 | |
98 | Phosphorylation | FAMTSFVTFEALEKD CHHHCEEHHHHHHHH | 17.47 | 27732954 | |
143 | Phosphorylation | HSKKSRLSHPHHYSS CCHHHCCCCCCCCCC | 33.59 | 27732954 | |
148 | Phosphorylation | RLSHPHHYSSDREND CCCCCCCCCCCCHHH | 13.56 | 27732954 | |
149 | Phosphorylation | LSHPHHYSSDRENDR CCCCCCCCCCCHHHH | 22.77 | 27732954 | |
150 | Phosphorylation | SHPHHYSSDRENDRN CCCCCCCCCCHHHHH | 33.26 | 27732954 | |
201 | Phosphorylation | SKGFHRSSSRERLSD CCCCCCCCCCCCCCC | 33.11 | 30576142 | |
202 (in isoform 3) | Phosphorylation | - | 39.13 | 22468782 | |
202 | Phosphorylation | KGFHRSSSRERLSDS CCCCCCCCCCCCCCC | 39.13 | 30576142 | |
210 | Phosphorylation | RERLSDSSAPSSLGT CCCCCCCCCCCCCCC | 49.54 | 30576142 | |
217 (in isoform 3) | Phosphorylation | - | 33.72 | 22468782 | |
255 | Phosphorylation | DPELGVGTLPEHDSQ CCCCCCCCCCCCCCC | 36.41 | 27732954 | |
261 | Phosphorylation | GTLPEHDSQDAGPIV CCCCCCCCCCCCCCC | 31.69 | 27732954 | |
319 | Phosphorylation | EPQLRAPSPDPDLVQ CCCCCCCCCCCCHHH | 40.73 | 30266825 | |
505 | O-linked_Glycosylation | LNTRFLASQSADRGA HHHHHHHHHCCCCCC | 27.15 | 29351928 | |
505 | Phosphorylation | LNTRFLASQSADRGA HHHHHHHHHCCCCCC | 27.15 | 30631047 | |
507 | Phosphorylation | TRFLASQSADRGASL HHHHHHHCCCCCCCC | 29.64 | 30631047 | |
510 | Methylation | LASQSADRGASLGPP HHHHCCCCCCCCCCC | 42.15 | - | |
513 | Phosphorylation | QSADRGASLGPPPYL HCCCCCCCCCCCCCC | 36.36 | 28555341 | |
578 | Phosphorylation | VDPFYRHSLFHSYPP CCHHHHHHHHHHCCC | 24.59 | - | |
673 | Phosphorylation | KVKKQMQSDPHKLDF HHHHHHCCCCCCCCC | 48.01 | 29396449 | |
799 | Phosphorylation | PWNRLHRTPPSFPTP CHHHHCCCCCCCCCC | 28.89 | 27732954 | |
802 | Phosphorylation | RLHRTPPSFPTPPPW HHCCCCCCCCCCCCC | 45.09 | 27080861 | |
805 | Phosphorylation | RTPPSFPTPPPWLKP CCCCCCCCCCCCCCC | 46.55 | 27080861 | |
832 | Phosphorylation | DRDRDVDKRDSSVSK HHCCCCCCCCCCCCC | 58.93 | 32645325 | |
852 | Phosphorylation | ESVEKRHSSHPSPAP HHHHHHHCCCCCCCC | 34.08 | 22496350 | |
853 | Phosphorylation | SVEKRHSSHPSPAPV HHHHHHCCCCCCCCC | 33.04 | 22496350 | |
856 | Phosphorylation | KRHSSHPSPAPVLPV HHHCCCCCCCCCCCC | 28.42 | 30576142 | |
898 | Phosphorylation | KERERDHSESRKDLA CHHHCCCHHHHHHHH | 41.37 | - | |
941 | Phosphorylation | KQLARVPSPYVRTPV HHHHCCCCCCCCCCC | 26.46 | 19664994 | |
943 | Phosphorylation | LARVPSPYVRTPVVE HHCCCCCCCCCCCHH | 13.60 | 26074081 | |
946 | Phosphorylation | VPSPYVRTPVVESAR CCCCCCCCCCHHCCC | 15.47 | 23312004 | |
951 | Phosphorylation | VRTPVVESARPNSTS CCCCCHHCCCCCCCC | 20.26 | 30108239 | |
956 | Phosphorylation | VESARPNSTSSREAE HHCCCCCCCCCCCCC | 32.14 | 30576142 | |
957 | Phosphorylation | ESARPNSTSSREAEP HCCCCCCCCCCCCCC | 37.04 | 30576142 | |
958 | Phosphorylation | SARPNSTSSREAEPR CCCCCCCCCCCCCCC | 27.50 | 30108239 | |
959 | Phosphorylation | ARPNSTSSREAEPRK CCCCCCCCCCCCCCC | 33.94 | 30108239 | |
971 | Phosphorylation | PRKGEPAYENPKKSS CCCCCCCCCCCCCCC | 27.27 | 27642862 | |
1053 | Phosphorylation | MTPFMGISPLPGGER CCCCCCCCCCCCCCC | 18.04 | 24719451 | |
1092 | Methylation | HRRDPLGRDFLLRND CCCCCCCCCCHHCCC | 38.91 | - | |
1103 | Methylation | LRNDPLHRLSTPRLY HCCCHHHHCCCCCHH | 37.71 | - | |
1105 | Phosphorylation | NDPLHRLSTPRLYEA CCHHHHCCCCCHHHC | 36.00 | 24719451 | |
1106 | Phosphorylation | DPLHRLSTPRLYEAD CHHHHCCCCCHHHCC | 19.61 | 24719451 | |
1108 | Methylation | LHRLSTPRLYEADRS HHHCCCCCHHHCCCC | 50.41 | - | |
1114 | Methylation | PRLYEADRSFRDREP CCHHHCCCCCCCCCC | 44.75 | - | |
1145 | Methylation | DPRREHERGGHLDER CCCCHHHCCCCCCHH | 59.30 | - | |
1162 | Phosphorylation | LHMLREDYEHTRLHS HHHHHHHHCHHCHHC | 12.59 | 28796482 | |
1174 | Phosphorylation | LHSVHPASLDGHLPH HHCCCHHHCCCCCCC | 31.29 | 32142685 | |
1183 | Phosphorylation | DGHLPHPSLITPGLP CCCCCCHHHCCCCCC | 29.39 | 28348404 | |
1186 | Phosphorylation | LPHPSLITPGLPSMH CCCHHHCCCCCCCCC | 19.32 | 28348404 | |
1194 | Phosphorylation | PGLPSMHYPRISPTA CCCCCCCCCCCCCCC | 5.88 | 33259812 | |
1198 | Phosphorylation | SMHYPRISPTAGNQN CCCCCCCCCCCCCCC | 19.92 | 30266825 | |
1200 | Phosphorylation | HYPRISPTAGNQNGL CCCCCCCCCCCCCCC | 40.17 | 30266825 | |
1201 | Phosphorylation | YPRISPTAGNQNGLL CCCCCCCCCCCCCCC | 20.51 | 32142685 | |
1209 | Phosphorylation | GNQNGLLNKTPPTAA CCCCCCCCCCCCCHH | 51.72 | 32142685 | |
1211 | Phosphorylation | QNGLLNKTPPTAALS CCCCCCCCCCCHHHC | 33.17 | 20363803 | |
1214 | Phosphorylation | LLNKTPPTAALSAPP CCCCCCCCHHHCCCC | 26.26 | 26074081 | |
1218 | Phosphorylation | TPPTAALSAPPPLIS CCCCHHHCCCCCCEE | 33.72 | 33259812 | |
1225 | Phosphorylation | SAPPPLISTLGGRPV CCCCCCEECCCCCCC | 25.84 | 23898821 | |
1226 | Phosphorylation | APPPLISTLGGRPVS CCCCCEECCCCCCCC | 23.56 | 22115753 | |
1233 | Phosphorylation | TLGGRPVSPRRTTPL CCCCCCCCCCCCCCC | 18.51 | 22617229 | |
1237 | Phosphorylation | RPVSPRRTTPLSAEI CCCCCCCCCCCCHHH | 33.76 | 30108239 | |
1238 | Phosphorylation | PVSPRRTTPLSAEIR CCCCCCCCCCCHHHH | 22.03 | 20363803 | |
1241 | Phosphorylation | PRRTTPLSAEIRERP CCCCCCCCHHHHHCC | 25.67 | 20363803 | |
1250 | Phosphorylation | EIRERPPSHTLKDIE HHHHCCCCCCCCHHH | 31.61 | 22817900 | |
1254 | Acetylation | RPPSHTLKDIEAR-- CCCCCCCCHHHCC-- | 58.79 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AUTS2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AUTS2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AUTS2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PCGF5_HUMAN | PCGF5 | physical | 25519132 | |
RING1_HUMAN | RING1 | physical | 25519132 | |
RING2_HUMAN | RNF2 | physical | 25519132 | |
RYBP_HUMAN | RYBP | physical | 25519132 | |
YAF2_HUMAN | YAF2 | physical | 25519132 | |
CSK21_HUMAN | CSNK2A1 | physical | 25519132 | |
CSK22_HUMAN | CSNK2A2 | physical | 25519132 | |
CSK2B_HUMAN | CSNK2B | physical | 25519132 | |
DCAF7_HUMAN | DCAF7 | physical | 25519132 | |
FBRS_HUMAN | FBRS | physical | 25519132 | |
PCGF3_HUMAN | PCGF3 | physical | 25519132 | |
EP300_HUMAN | EP300 | physical | 25519132 | |
RERE_HUMAN | RERE | physical | 25519132 | |
RBM14_HUMAN | RBM14 | physical | 25519132 | |
ZN608_HUMAN | ZNF608 | physical | 25519132 | |
ZN609_HUMAN | ZNF609 | physical | 25519132 | |
TLE3_HUMAN | TLE3 | physical | 25519132 | |
WDR5_HUMAN | WDR5 | physical | 25519132 | |
PCGF6_HUMAN | PCGF6 | physical | 25519132 | |
ATN1_HUMAN | ATN1 | physical | 25519132 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615834 | Mental retardation, autosomal dominant 26 (MRD26) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1233, AND MASSSPECTROMETRY. |